Growth Metrics

Pacific Biosciences Of California (PACB) Short term Debt (2021 - 2023)

Pacific Biosciences Of California (PACB) has 5 years of Short term Debt data on record, last reported at $96.2 million in Q3 2023.

  • For Q3 2023, Short term Debt changed N/A year-over-year to $96.2 million; the TTM value through Sep 2023 reached $96.2 million, changed N/A, while the annual FY2022 figure was $172.1 million, N/A changed from the prior year.
  • Short term Debt reached $96.2 million in Q3 2023 per PACB's latest filing, down from $186.3 million in the prior quarter.
  • Across five years, Short term Debt topped out at $186.3 million in Q2 2023 and bottomed at $96.2 million in Q3 2023.